{"id":6621,"date":"2025-09-03T11:51:29","date_gmt":"2025-09-03T09:51:29","guid":{"rendered":"https:\/\/mediconomics.com\/glossar\/study-coordinator\/"},"modified":"2026-08-24T22:06:24","modified_gmt":"2026-08-24T20:06:24","slug":"study-coordinator","status":"publish","type":"glossary","link":"https:\/\/mediconomics.com\/en\/glossar\/study-coordinator\/","title":{"rendered":"Study Coordinator"},"content":{"rendered":"<p>A study coordinator organizes the daily conduct of a clinical trial at the trial site. The role supports the trial team under the responsibility of the investigator in administrative, logistical, and documentation-related study tasks. \u201cStudy coordinator\u201d is a functional designation used in clinical practice and not an independent regulatory role defined in Regulation (EU) No 536\/2014.<\/p>\n<h2>Role at the trial site<\/h2>\n<p>The study coordinator is part of the trial site team, for example at a hospital, medical practice, or research institution. They are responsible for the operational preparation, coordination, and follow-up of study activities at the site. The role is expressly not located with the sponsor, even though the study coordinator works with the sponsor\u2019s project team or a contracted CRO in day-to-day activities.<\/p>\n<p>Typical tasks include scheduling trial visits, preparing examinations, communicating with participants within the scope of delegated activities, maintaining trial site documentation, and coordinating laboratory, sample, or investigational medicinal product processes. The study coordinator also frequently supports the preparation of monitoring visits, the processing of data queries, and the follow-up of outstanding items.<\/p>\n<p>Which tasks are specifically permissible and appropriate results from the protocol, applicable legislation, the requirements of the trial site, and the documented delegation. The term therefore does not describe a standardized job description. The scope and area of responsibility vary, for example, according to the indication, the complexity of the trials, available resources, and local procedures.<\/p>\n<h2>Delegation, qualifications, and documentation<\/h2>\n<p>Under ICH E6(R3), the investigator may delegate trial-related activities to other persons or entities. However, they retain ultimate responsibility and must ensure appropriate oversight so that the rights, safety, and well-being of participants, as well as the reliability of the data, are protected. Regulation (EU) No 536\/2014 also requires that other persons involved in the trial be appropriately qualified for their tasks through education, training, and experience.<\/p>\n<p>For study coordinators, this means task-specific, documented induction and training. This regularly includes the study protocol, study-specific procedures, source data recording, data protection and confidentiality requirements, safety reporting channels, and the handling of the investigational medicinal product. Training should correspond to the scope of the delegated activity and be updated when the protocol or processes change.<\/p>\n<p>The delegation must be traceable at the trial site. A delegation log may specify tasks, the start and end of the delegation, and the persons involved. However, it neither replaces professional qualifications nor the required oversight by the investigator. Careful documentation facilitates monitoring and inspections because it makes it visible who performed which task within the trial team.<\/p>\n<h2>Distinction from the investigator and monitor<\/h2>\n<p>The investigator is responsible for the proper conduct of the clinical trial at the trial site. The principal investigator ensures under the Regulation that the trial at the site complies with regulatory requirements and allocates tasks within the trial team in a way that does not compromise safety or data reliability. A study coordinator supports the investigator in this, but does not assume their ultimate responsibility or the medical assessment requiring a medical decision.<\/p>\n<p>The monitor, often referred to as a Clinical Research Associate, typically performs a monitoring function for the sponsor or a CRO. Based on a monitoring plan, the monitor reviews conduct, documentation, and data quality at the trial sites and follows up on deviations or outstanding items. The study coordinator performs the day-to-day activities at the site; the monitor does not direct these activities as a member of the trial site.<\/p>\n<p>The distinction is particularly important for safety issues. A study coordinator may provide organizational support for recording and forwarding a serious adverse event. The medical assessment, responsibility for participant safety, and appropriate oversight remain with the investigator. Delegation does not release the investigator from these obligations.<\/p>\n<h2>Relevance for clinical trials<\/h2>\n<p>For trial quality, it is crucial that the distribution of tasks at the trial site is clear, adequately resourced, and documented. A study coordinator supports protocol-compliant organization, complete trial documentation, and prompt communication with the trial team. Monitoring and quality management can then specifically assess whether delegation, training status, source data, and the handling of safety or data processes are consistent with one another.<\/p>\n<p>Full-service CROs such as Mediconomics support study planning, trial site selection, site initiation, training, monitoring, data management, and safety communication. This includes clearly structuring interfaces with study coordinators at the trial sites, following up on outstanding items, and translating the operational requirements of the protocol into practicable procedures.<\/p>\n<h2>Frequently Asked Questions (FAQ)<\/h2>\n<p><strong>Is a study coordinator employed by the sponsor?<\/strong><\/p>\n<p>In the role understanding described here, the study coordinator works at the trial site and supports the trial team there. This is distinct from functions at the sponsor or a CRO, such as project management or monitoring. The contractual form of employment may vary depending on the site, but this does not change the assignment of the activity to the trial site.<\/p>\n<p><strong>May a study coordinator perform tasks of the investigator?<\/strong><\/p>\n<p>The investigator may delegate trial-related activities to qualified persons. They retain ultimate responsibility and must ensure oversight. Medical decisions and responsibility for proper conduct at the trial site do not transfer to the study coordinator through their support.<\/p>\n<p><strong>Why is a delegation log important?<\/strong><\/p>\n<p>It makes it possible to trace which activity was assigned to a qualified person and helps the trial team manage tasks, training, and responsibilities in an orderly manner. During monitoring or inspections, it supports the assessment of whether trial activities at the trial site were appropriately organized.<\/p>\n<h2>Regulatory references<\/h2>\n<ul>\n<li>ICH E6(R3) Guideline for Good Clinical Practice, Section 2.3 \u2013 governs delegation and oversight by the investigator.<\/li>\n<li>Regulation (EU) No 536\/2014, Article 49 \u2013 contains requirements for investigators, the qualifications of other persons, and the allocation of tasks at the trial site.<\/li>\n<li>Regulation (EU) No 536\/2014, Article 72 \u2013 determines the sponsor\u2019s responsibility despite the possible delegation of its own tasks.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>A study coordinator organizes the daily conduct of a clinical trial at the trial site. The role supports the trial team under the responsibility of the investigator in administrative, logistical, and documentation-related study tasks. \u201cStudy coordinator\u201d is a functional designation used in clinical practice and not an independent regulatory role defined in Regulation (EU) No [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":0,"parent":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"glossary-cat":[],"class_list":["post-6621","glossary","type-glossary","status-publish","hentry"],"acf":[],"related_terms":"","external_url":"","internal_reference_id":"","_links":{"self":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/6621","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary"}],"about":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/types\/glossary"}],"author":[{"embeddable":true,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/users\/10"}],"version-history":[{"count":1,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/6621\/revisions"}],"predecessor-version":[{"id":7452,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/6621\/revisions\/7452"}],"wp:attachment":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/media?parent=6621"}],"wp:term":[{"taxonomy":"glossary-cat","embeddable":true,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary-cat?post=6621"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}